Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Prognostic Factors for Colorectal Cancer Patients Treated With Combination of Immune-cell Therapy and First-line Chemotherapy: A Retrospective Study.

Takimoto R, Kamigaki T, Okada S, Matsuda E, Ibe H, Oguma E, Naitoh K, Makita K, Goto S.

Anticancer Res. 2019 Aug;39(8):4525-4532. doi: 10.21873/anticanres.13629.

PMID:
31366555
2.

DIHS/DRESS-like eruption possibly induced by amoxicillin during treatment with nivolumab.

Takimoto R, Honda T, Kataoka TR, Ueshima C, Otsuka A, Kabashima K.

Eur J Dermatol. 2019 Apr 1;29(2):228-229. doi: 10.1684/ejd.2019.3522. No abstract available.

PMID:
30973334
3.

Relationship between Ventilator-Associated Events and Timing of Rehabilitation in Subjects with Emergency Tracheal Intubation at Early Mobilization Facility.

Shinoda T, Nishihara H, Shimogai T, Ito T, Takimoto R, Seo R, Kanai M, Izawa KP, Iwata K.

Int J Environ Res Public Health. 2018 Dec 17;15(12). pii: E2892. doi: 10.3390/ijerph15122892.

4.

Prognostic Factors for Pancreatic Cancer Patients Treated with Immune-cell Therapy.

Makita K, Kamigaki T, Okada S, Matsuda E, Ibe H, Oguma E, Naitoh K, Takimoto R, Goto S.

Anticancer Res. 2018 Jul;38(7):4353-4360. doi: 10.21873/anticanres.12736.

PMID:
29970573
5.

No recurrence of nivolumab-induced idiopathic thrombocytopenic purpura in a metastatic melanoma patient switched to ipilimumab.

Takimoto R, Otsuka A, Kaku Y, Honda T, Kabashima K.

Eur J Dermatol. 2018 Feb 1;28(1):84-85. doi: 10.1684/ejd.2017.3151. No abstract available.

PMID:
29400292
6.

Efficacy of Adoptive Immune-cell Therapy in Patients with Advanced Gastric Cancer: A Retrospective Study.

Takimoto R, Kamigaki T, Okada S, Matsuda E, Ibe H, Oguma E, Naitoh K, Makita K, Goto S.

Anticancer Res. 2017 Jul;37(7):3947-3954.

PMID:
28668899
7.

The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.

Tomita N, Yokoyama M, Yamamoto W, Watanabe R, Shimazu Y, Masaki Y, Tsunoda S, Hashimoto C, Murayama K, Yano T, Okamoto R, Kikuchi A, Tamura K, Sato K, Sunami K, Shibayama H, Takimoto R, Ohshima R, Takahashi H, Moriuchi Y, Kinoshita T, Yamamoto M, Numata A, Nakajima H, Miura I, Takeuchi K.

Leuk Lymphoma. 2018 Jan;59(1):97-104. doi: 10.1080/10428194.2017.1330541. Epub 2017 Jun 8.

PMID:
28593796
8.

Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin.

Ono M, Takimoto R, Osuga T, Okagawa Y, Hirakawa M, Yoshida M, Arihara Y, Uemura N, Hayasaka N, Miura S, Matsuno T, Tamura F, Sato Y, Sato T, Iyama S, Miyanishi K, Takada K, Kobune M, Kato J.

Oncotarget. 2016 Jun 21;7(25):38586-38597. doi: 10.18632/oncotarget.9558.

9.

Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal Cancer.

Osuga T, Takimoto R, Ono M, Hirakawa M, Yoshida M, Okagawa Y, Uemura N, Arihara Y, Sato Y, Tamura F, Sato T, Iyama S, Miyanishi K, Takada K, Hayashi T, Kobune M, Kato J.

J Natl Cancer Inst. 2016 Sep 14;108(9). pii: djw210. doi: 10.1093/jnci/djw210. Print 2016 Sep. Retraction in: J Natl Cancer Inst. 2016 Sep 14;108(9):.

PMID:
27628655
10.

Isoform D of vascular endothelial growth factor in systemic capillary leak syndrome: a case report.

Ibata S, Sato T, Takada K, Tatekoshi A, Hashimoto A, Kamihara Y, Jomen W, Horiguchi H, Ono K, Murase K, Iyama S, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J.

J Med Case Rep. 2016 May 24;10:125. doi: 10.1186/s13256-016-0894-7.

11.

Immunohistochemical Analysis of WT1 Antigen Expression in Various Solid Cancer Cells.

Naitoh K, Kamigaki T, Matsuda E, Ibe H, Okada S, Oguma E, Kinoshita Y, Takimoto R, Makita K, Ogasawara S, Goto S.

Anticancer Res. 2016 Jul;36(7):3715-24.

PMID:
27354645
12.

Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal Cancer.

Osuga T, Takimoto R, Ono M, Hirakawa M, Yoshida M, Okagawa Y, Uemura N, Arihara Y, Sato Y, Tamura F, Sato T, Iyama S, Miyanishi K, Takada K, Hayashi T, Kobune M, Kato J.

J Natl Cancer Inst. 2016 Apr 13;108(8). doi: 10.1093/jnci/djw038. Print 2016 Aug.

13.

[Neurolymphomatosis of the sciatic nerve diagnosed by FDG-PET/CT].

Usami M, Murase K, Takada K, Iijima K, Yoshida M, Tatekoshi A, Hashimoto A, Iyama S, Sato T, Kobune M, Takimoto R, Kaya M, Yamashita T, Morita R, Hasegawa T, Kato J.

Rinsho Ketsueki. 2016 Jan;57(1):52-5. doi: 10.11406/rinketsu.57.52. Japanese.

PMID:
26861105
14.

BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer.

Kubo T, Kawano Y, Himuro N, Sugita S, Sato Y, Ishikawa K, Takada K, Murase K, Miyanishi K, Sato T, Takimoto R, Kobune M, Nobuoka T, Hirata K, Takayama T, Mori M, Hasegawa T, Kato J.

Gastric Cancer. 2016 Jul;19(3):827-38. doi: 10.1007/s10120-015-0557-1. Epub 2015 Oct 20.

PMID:
26486506
15.

[Therapy-related myelodysplastic syndrome as a late adverse event of definitive chemoradiotherapy for esophageal and oropharyngeal cancer].

Kamihara Y, Sato Y, Takada K, Okagawa Y, Iyama S, Sato T, Miyanishi K, Takimoto R, Kobune M, Kato J.

Nihon Shokakibyo Gakkai Zasshi. 2015;112(9):1664-73. doi: 10.11405/nisshoshi.112.1664. Review. Japanese.

PMID:
26346357
16.

A Phase 1/2 Study of Definitive Chemoradiation Therapy Using Docetaxel, Nedaplatin, and 5-Fluorouracil (DNF-R) for Esophageal Cancer.

Ohnuma H, Sato Y, Hirakawa M, Okagawa Y, Osuga T, Hayashi T, Sato T, Miyanishi K, Kobune M, Takimoto R, Sagawa T, Hori M, Someya M, Nakata K, Sakata K, Takayama T, Kato J.

Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):382-90. doi: 10.1016/j.ijrobp.2015.05.041. Epub 2015 Jun 3.

PMID:
26232855
17.

[A Case of Fanconi Syndrome Induced by Zoledronic Acid in a Metastatic Colorectal Cancer Patient].

Okagawa Y, Sato Y, Onuma H, Osuga T, Hayashi T, Sato T, Miyanishi K, Kobune M, Takimoto R, Kato J.

Gan To Kagaku Ryoho. 2015 Jul;42(7):867-70. Japanese.

PMID:
26197752
18.

Clinical utility of capsule endoscopy with flexible spectral imaging color enhancement for diagnosis of small bowel lesions.

Sato Y, Sagawa T, Hirakawa M, Ohnuma H, Osuga T, Okagawa Y, Tamura F, Horiguchi H, Takada K, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Kato J.

Endosc Int Open. 2014 Jun;2(2):E80-7. doi: 10.1055/s-0034-1365526. Epub 2014 May 7.

19.

Trastuzumab in combination with docetaxel/cisplatin/S-1 (DCS) for patients with HER2-positive metastatic gastric cancer: feasibility and preliminary efficacy.

Mitsui Y, Sato Y, Miyamoto H, Fujino Y, Takaoka T, Miyoshi J, Kagawa M, Ohnuma H, Hirakawa M, Kubo T, Osuga T, Sagawa T, Sato Y, Takahashi Y, Katsuki S, Okuda T, Takimoto R, Kobune M, Nobuoka T, Hirata K, Kato J, Takayama T.

Cancer Chemother Pharmacol. 2015 Aug;76(2):375-82. doi: 10.1007/s00280-015-2807-7. Epub 2015 Jun 23.

PMID:
26099968
20.

Evaluation of the validity of chemotherapy-induced nausea and vomiting assessment in outpatients using the Japanese version of the MASCC antiemesis tool.

Matsuda Y, Okita K, Furuhata T, Kutomi G, Yamashita K, Sato Y, Takimoto R, Hirata K.

Support Care Cancer. 2015 Nov;23(11):3331-9. doi: 10.1007/s00520-015-2780-z. Epub 2015 May 24.

PMID:
26003425
21.

[Disorder of glucose metabolism (hypoglycemia, hyperglycemia)].

Takimoto R.

Nihon Rinsho. 2015 Feb;73 Suppl 2:436-40. Japanese. No abstract available.

PMID:
25831798
22.

Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.

Hirayama Y, Ishitani K, Sato Y, Iyama S, Takada K, Murase K, Kuroda H, Nagamachi Y, Konuma Y, Fujimi A, Sagawa T, Ono K, Horiguchi H, Terui T, Koike K, Kusakabe T, Sato T, Takimoto R, Kobune M, Kato J.

Int J Clin Oncol. 2015 Oct;20(5):866-71. doi: 10.1007/s10147-015-0810-y. Epub 2015 Mar 12.

PMID:
25762165
23.

Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis.

Hoki T, Miyanishi K, Tanaka S, Takada K, Kawano Y, Sakurada A, Sato M, Kubo T, Sato T, Sato Y, Takimoto R, Kobune M, Kato J.

Hepatology. 2015 Sep;62(3):751-61. doi: 10.1002/hep.27774. Epub 2015 Apr 8.

PMID:
25753988
24.

Phase I trial of oral S-1 combined with hepatic arterial infusion of gemcitabine in unresectable biliary tract cancer.

Ishiwatari H, Hayashi T, Yoshida M, Ono M, Sato T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J.

Cancer Chemother Pharmacol. 2015 Apr;75(4):805-12. doi: 10.1007/s00280-015-2704-0. Epub 2015 Feb 17.

PMID:
25687990
25.

EUS-guided celiac plexus neurolysis by using highly viscous phenol-glycerol as a neurolytic agent (with video).

Ishiwatari H, Hayashi T, Yoshida M, Ono M, Sato T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Masuko H, Miyamoto A, Sonoda T, Kato J.

Gastrointest Endosc. 2015 Feb;81(2):479-83. doi: 10.1016/j.gie.2014.10.031. No abstract available.

PMID:
25616759
26.

A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer.

Sato Y, Ohnuma H, Hirakawa M, Takahashi M, Osuga T, Okagawa Y, Murase K, Takada K, Kawano Y, Iyama S, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Okita K, Mizuguchi T, Furuhata T, Hirata K, Kato J.

Cancer Chemother Pharmacol. 2015 Mar;75(3):587-94. doi: 10.1007/s00280-014-2672-9. Epub 2015 Jan 11.

PMID:
25577134
27.

RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells.

Tamura F, Sato Y, Hirakawa M, Yoshida M, Ono M, Osuga T, Okagawa Y, Uemura N, Arihara Y, Murase K, Kawano Y, Iyama S, Takada K, Hayashi T, Sato T, Miyanishi K, Kobune M, Takimoto R, Kato J.

Gastric Cancer. 2016 Jan;19(1):85-97. doi: 10.1007/s10120-014-0454-z. Epub 2014 Dec 23.

PMID:
25532910
28.

Markers of bone metabolism in multiple myeloma patients switched from zoledronic acid to denosumab.

Tatekoshi A, Sato T, Ibata S, Hashimoto A, Kamihara Y, Horiguchi H, Ono K, Takada K, Iyama S, Takimoto R, Kobune M, Kato J.

Rinsho Ketsueki. 2014 Nov;55(11):2271-6. Japanese.

PMID:
25501406
29.

Efficacy of Enteral Supplementation Enriched with Glutamine, Fiber, and Oligosaccharide on Mucosal Injury following Hematopoietic Stem Cell Transplantation.

Iyama S, Sato T, Tatsumi H, Hashimoto A, Tatekoshi A, Kamihara Y, Horiguchi H, Ibata S, Ono K, Murase K, Takada K, Sato Y, Hayashi T, Miyanishi K, Akizuki E, Nobuoka T, Mizugichi T, Takimoto R, Kobune M, Hirata K, Kato J.

Case Rep Oncol. 2014 Oct 22;7(3):692-9. doi: 10.1159/000368714. eCollection 2014 Sep.

30.

Radiation-induced leiomyosarcoma of the prostate after brachytherapy for prostatic adenocarcinoma.

Horiguchi H, Takada K, Kamihara Y, Ibata S, Iyama S, Sato T, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kobayashi K, Hirayama Y, Masumori N, Hasegawa T, Kato J.

Case Rep Oncol. 2014 Aug 16;7(2):565-70. doi: 10.1159/000366294. eCollection 2014 May.

31.

Phenol-based endoscopic ultrasound-guided celiac plexus neurolysis for East Asian alcohol-intolerant upper gastrointestinal cancer patients: a pilot study.

Ishiwatari H, Hayashi T, Yoshida M, Ono M, Masuko H, Sato T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Miyamoto A, Sonoda T, Kato J.

World J Gastroenterol. 2014 Aug 14;20(30):10512-7. doi: 10.3748/wjg.v20.i30.10512.

32.

[Effective treatment of metastatic rhabdomyosarcoma with pazopanib].

Hashimoto A, Takada K, Takimoto R, Horiguchi H, Sato T, Iyama S, Murase K, Ono K, Tatekoshi A, Hayashi T, Miyanishi K, Sato Y, Kobune M, Hirayama Y, Kitamura H, Nakanishi K, Masumori N, Hasegawa T, Kato J.

Gan To Kagaku Ryoho. 2014 Aug;41(8):1041-4. Japanese.

PMID:
25132042
33.

Successful treatment with entecavir for reactivation of hepatitis B virus following systemic chemotherapy in a hepatitis B surface antigen-negative patient with colorectal cancer.

Okagawa Y, Takada K, Hisai H, Koshiba Y, Wada H, Miyazaki E, Kanari Y, Kawano Y, Iyama S, Hayashi T, Sato T, Sato Y, Miyanishi K, Kobune M, Takimoto R, Kato J.

Intern Med. 2014;53(16):1759-62. Epub 2014 Aug 15.

34.

Long-term survey of survival time, histological transformation, and secondary malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study Group.

Hirayama Y, Ishitani K, Ota S, Kurosawa M, Kondo T, Takimoto R, Mori A, Sakai H, Torimoto Y, Yamamoto S, Sato K, Iwasaki H, Kohda K, Ishida T, Kakinoki Y, Fukuhara T, Kato J.

Int J Hematol. 2014 Sep;100(3):281-9. doi: 10.1007/s12185-014-1629-4. Epub 2014 Jul 23.

PMID:
25052874
35.

Combination Chemotherapy of Azacitidine and Cetuximab for Therapy-Related Acute Myeloid Leukemia following Oxaliplatin for Metastatic Colorectal Cancer.

Hashimoto A, Takada K, Horiguchi H, Sato T, Iyama S, Murase K, Kamihara Y, Ono K, Tatekoshi A, Hayashi T, Miyanishi K, Sato Y, Furuhata T, Kobune M, Takimoto R, Hirata K, Kato J.

Case Rep Oncol. 2014 May 17;7(2):316-22. doi: 10.1159/000363100. eCollection 2014 May.

36.

Narrowband ultraviolet B phototherapy ameliorates acute graft-versus-host disease by a mechanism involving in vivo expansion of CD4+CD25+Foxp3+ regulatory T cells.

Iyama S, Murase K, Sato T, Hashimoto A, Tatekoshi A, Horiguchi H, Kamihara Y, Ono K, Kikuchi S, Takada K, Kawano Y, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Mori S, Kato J, Yamashita T, Kato J.

Int J Hematol. 2014 Apr;99(4):471-6. doi: 10.1007/s12185-014-1530-1. Epub 2014 Feb 21.

PMID:
24557710
37.

A novel strategy inducing autophagic cell death in Burkitt's lymphoma cells with anti-CD19-targeted liposomal rapamycin.

Ono K, Sato T, Iyama S, Tatekoshi A, Hashimoto A, Kamihara Y, Horiguchi H, Kikuchi S, Kawano Y, Takada K, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J.

Blood Cancer J. 2014 Feb 7;4:e180. doi: 10.1038/bcj.2014.2.

38.

Pancreatic metastasis from a solitary fibrous tumor of the central nervous system.

Osuga T, Hayashi T, Ishiwatari H, Ono M, Yoshida M, Kimura Y, Hasegawa T, Sato Y, Sato T, Miyanishi K, Takimoto R, Kobune M, Kato J.

JOP. 2014 Jan 10;15(1):58-62. doi: 10.6092/1590-8577/1764. Review.

39.

[Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].

Ono K, Sato T, Iyama S, Tatekoshi A, Hashimoto A, Kamihara Y, Horiguchi H, Kikuchi S, Takada K, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J.

Rinsho Ketsueki. 2013 Nov;54(11):2053-5. Japanese.

PMID:
24305538
40.

Fucosylated TGF-β receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells.

Hirakawa M, Takimoto R, Tamura F, Yoshida M, Ono M, Murase K, Sato Y, Osuga T, Sato T, Iyama S, Miyanishi K, Takada K, Hayashi T, Kobune M, Kato J.

Br J Cancer. 2014 Jan 7;110(1):156-63. doi: 10.1038/bjc.2013.699. Epub 2013 Nov 19.

41.

A case of idiopathic encapsulating peritoneal sclerosis with intractable ileus successfully treated by surgery and steroid therapy.

Ikeda Y, Sato Y, Kamihara Y, Hirakawa M, Onuma H, Takada K, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kohune M, Nobuoka T, Noguchi H, Oi M, Honma H, Hirata K, Hasegawa T, Kato J.

Clin J Gastroenterol. 2013 Aug;6(4):295-8. doi: 10.1007/s12328-013-0395-9. Epub 2013 Jun 20.

PMID:
26181733
42.

A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group.

Torimoto Y, Sato K, Ikuta K, Hayashi T, Hirayama Y, Inamura J, Kobayashi H, Kobayashi R, Koda K, Kurosawa M, Mori A, Ota S, Sakai H, Shigematsu A, Shindo M, Shinzaki H, Takahashi F, Takimoto R, Tanaka J, Yamamoto S, Kohgo Y, Fukuhara T.

Int J Hematol. 2013 Aug;98(2):171-8. doi: 10.1007/s12185-013-1383-z. Epub 2013 Jun 29.

PMID:
23813410
43.

A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.

Hirakawa M, Sato Y, Ohnuma H, Takayama T, Sagawa T, Nobuoka T, Harada K, Miyamoto H, Sato Y, Takahashi Y, Katsuki S, Hirayama M, Takahashi M, Ono M, Maeda M, Takada K, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Hirata K, Kato J.

Cancer Chemother Pharmacol. 2013 Mar;71(3):789-97. doi: 10.1007/s00280-013-2073-5. Epub 2013 Jan 22.

PMID:
23338051
44.

Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.

Tanaka S, Miyanishi K, Kobune M, Kawano Y, Hoki T, Kubo T, Hayashi T, Sato T, Sato Y, Takimoto R, Kato J.

J Gastroenterol. 2013 Nov;48(11):1249-58. doi: 10.1007/s00535-012-0739-0. Epub 2013 Jan 19.

PMID:
23329365
45.

Rapid on-site evaluation by endosonographer during endoscopic ultrasound-guided fine needle aspiration for pancreatic solid masses.

Hayashi T, Ishiwatari H, Yoshida M, Ono M, Sato T, Miyanishi K, Sato Y, Kobune M, Takimoto R, Mitsuhashi T, Asanuma H, Ogino J, Hasegawa T, Sonoda T, Kato J.

J Gastroenterol Hepatol. 2013 Apr;28(4):656-63. doi: 10.1111/jgh.12122.

PMID:
23301574
46.

Facial reconstruction with a bone-anchored prosthesis following destructive cancer surgery.

Mello MC, Piras JA, Takimoto RM, Cervantes O, Abraão M, Dib LL.

Oncol Lett. 2012 Oct;4(4):682-684. Epub 2012 Jul 20.

47.

Diagnostic validity of CT gastrography versus gastroscopy for primary lesions in gastric cancer: evaluating the response to chemotherapy, a retrospective analysis.

Takahashi S, Hirayama M, Kuroiwa G, Kawano Y, Takada K, Sato T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J.

Gastric Cancer. 2013 Oct;16(4):543-8. doi: 10.1007/s10120-012-0217-7. Epub 2012 Nov 29.

PMID:
23187880
48.

Treatment of pancreatic fibrosis with siRNA against a collagen-specific chaperone in vitamin A-coupled liposomes.

Ishiwatari H, Sato Y, Murase K, Yoneda A, Fujita R, Nishita H, Birukawa NK, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Ota S, Kimura Y, Hirata K, Kato J, Niitsu Y.

Gut. 2013 Sep;62(9):1328-39. doi: 10.1136/gutjnl-2011-301746. Epub 2012 Nov 20.

PMID:
23172890
49.

Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.

Kurosawa M, Yonezumi M, Hashino S, Tanaka J, Nishio M, Kaneda M, Ota S, Koda K, Suzuki N, Yoshida M, Hirayama Y, Takimoto R, Torimoto Y, Mori A, Takahashi T, Iizuka S, Ishida T, Kobayashi R, Oda T, Sakai H, Yamamoto S, Takahashi F, Fukuhara T.

Int J Hematol. 2012 Dec;96(6):748-57. doi: 10.1007/s12185-012-1210-y. Epub 2012 Oct 31.

PMID:
23111539
50.

Stromal cells expressing hedgehog-interacting protein regulate the proliferation of myeloid neoplasms.

Kobune M, Iyama S, Kikuchi S, Horiguchi H, Sato T, Murase K, Kawano Y, Takada K, Ono K, Kamihara Y, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kato J.

Blood Cancer J. 2012 Sep 7;2:e87. doi: 10.1038/bcj.2012.36.

Supplemental Content

Loading ...
Support Center